These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9682709)

  • 1. Worsening of diabetic retinopathy after improvement of glycemic control.
    Davis MD
    Arch Ophthalmol; 1998 Jul; 116(7):931-2. PubMed ID: 9682709
    [No Abstract]   [Full Text] [Related]  

  • 2. Oscillatory potentials, retinopathy, and long-term glucose control in insulin-dependent diabetes.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):705-12. PubMed ID: 1488874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus.
    Roysarkar TK; Gupta A; Dash RJ; Dogra MR
    Am J Ophthalmol; 1993 May; 115(5):569-74. PubMed ID: 8488908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal function in relation to improved glycaemic control in type 1 diabetes.
    Holfort SK; Nørgaard K; Jackson GR; Hommel E; Madsbad S; Munch IC; Klemp K; Sander B; Larsen M
    Diabetologia; 2011 Jul; 54(7):1853-61. PubMed ID: 21516521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.
    Verrillo A; de Teresa A; Martino C; Verrillo L; di Chiara G
    Diabetes Res; 1988 Jun; 8(2):71-6. PubMed ID: 3067950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic memory: mechanisms and implications for diabetic retinopathy.
    Zhang L; Chen B; Tang L
    Diabetes Res Clin Pract; 2012 Jun; 96(3):286-93. PubMed ID: 22209677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.
    Chantelau E
    Diabetes Metab; 2001 Jun; 27(3):366-71. PubMed ID: 11431602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose control and vision outcome in diabetes.
    Minckler D
    Ophthalmology; 1995 May; 102(5):703-4. PubMed ID: 7777267
    [No Abstract]   [Full Text] [Related]  

  • 12. Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Acta Ophthalmol (Copenh); 1992 Apr; 70(2):235-42. PubMed ID: 1609574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the metabolic control on latency values of visual evoked potentials (VEP) in patients with diabetes mellitus type 1.
    Matanovic D; Popovic S; Parapid B; Petronic I; Cirovic D; Nikolic D
    Arch Ital Biol; 2012 Dec; 150(4):251-8. PubMed ID: 23479458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased formation of aqueous humour in insulin-dependent diabetic patients.
    Hayashi M; Yablonski ME; Boxrud C; Fong N; Berger C; Jovanovic LJ
    Br J Ophthalmol; 1989 Aug; 73(8):621-3. PubMed ID: 2765440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pregnancy on progression of diabetic retinopathy.
    Klein BE; Moss SE; Klein R
    Diabetes Care; 1990 Jan; 13(1):34-40. PubMed ID: 2404715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for progression of background retinopathy in long-standing IDDM.
    Janka HU; Warram JH; Rand LI; Krolewski AS
    Diabetes; 1989 Apr; 38(4):460-4. PubMed ID: 2647552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A summary of the ADVANCE Trial.
    Heller SR;
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of diabetic control on diabetic retinopathy.
    Kohner EM
    Eye (Lond); 1993; 7 ( Pt 2)():309-11. PubMed ID: 7607352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
    Bain SC; Klufas MA; Ho A; Matthews DR
    Diabetes Obes Metab; 2019 Mar; 21(3):454-466. PubMed ID: 30226298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
    Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
    Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.